Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-4 Registration of securities issued in business combination transactions
- 3.1 Certificate of Incorporation of Allarity Therapeutics, Inc
- 3.2 Bylaws of Allarity Therapeutics, Inc
- 4.2 Form of Warrant
- 10.2 Exclusive License Agreement Between Oncology Venture A/s and Smerud Medical Research International As Dated As of June 26, 2020
- 10.3 Amended and Restated License Agreement Between Allarity Therapeutics A/s and Liplasome Pharma Aps, Dated January 2021
- 10.4 Exclusive License Agreement Between Oncology Venture, Aps and 2-BBB Medicines BV, Dated As of March 27, 2017
- 10.5 Development, Option and License Agreement Between Oncology Venture Aps and R-pharm Us Operating LLC, Dated March 1, 2019
- 10.6 Exclusive License Agreement Between Oncology Venture, Aps and Eisai, Inc., Dated As of July 6, 2017
- 10.7 License Agreement Between Novartis Pharma Ag and Oncology Venture, Aps, Dated April 6, 2018
- 10.8 Securities Purchase Agreement Dated May 20, 2021 Between Allarity Therapeutics, Inc. and 3I, LLP
- 10.9 Registration Rights Agreement Dated May 20, 2021 Between Allarity Therapeutics, Inc. and 3I, LLP
- 10.10 Asset Purchase Agreement Between Allarity Therapeutics A/s and Lantern Pharma Inc
- 16.1 Letter from Pricewaterhousecoopers, Dated August 20, 2021, Regarding Change In Independent Registered Public Accounting Firm
- 21.1 Subsidiaries of the Registrant
- 23.1 Consent of Pricewaterhousecoopers
ALLR similar filings
- 20 Oct 21 Registration of securities issued in business combination transactions (amended)
- 18 Oct 21 Registration of securities issued in business combination transactions (amended)
- 29 Sep 21 Registration of securities issued in business combination transactions (amended)
- 20 Aug 21 Registration of securities issued in business combination transactions
Filing view
External links